Cypionate is a long-acting injectable ester of testosterone. Testosterone is also the main anabolic hormone in men and is the base substrate for comparison of all other anabolic/androgenic steroids. Like all testosterone injections, testosterone cypionate is favored by athletes for its ability to promote increases in muscle mass and strength. It is worth noting that 6 even though a plethora of other steroids have emerged since testosterone injections, they are still considered workhorses among bodybuilders.
Testosterone Cypionate History:
Testosterone cypionate first appeared on the U.S. drug market in the mid-1950s under the brand name Depo-Testosterone cyclopentylpropionate (soon to be shortened to Depo-Testosterone). It was developed by pharmaceutical giant Upjohn and is still sold under the same trade name by the same company (although they are now called Pharmacia & Upjohn). This is a drug with limited global availability, and has historically been (mostly) identified as a US program because it is largely uncommon or non-existent in other countries. Not surprisingly, American athletes have long preferred testosterone cypionate, the main slow-acting ester of testosterone on the global market, over testosterone enanthate. However, this preference may stem from history and availability rather than actual therapeutic advantage.
Testosterone cypionate in the medical field:
Testosterone cypionate and testosterone enanthate provide extremely comparable testosterone release patterns. Not only is physical superiority impossible over one, but actual differences in pharmacokinetic patterns are hardly noticeable (the two drugs are, for all intents and purposes, functionally interchangeable). The only key difference between the two appears to be user comfort. For a small proportion of patients, cypionate is less irritating than enanthate at the injection site. This makes testosterone cypropionate a more favorable option for those who have recurring problems with enanthate injection site pain. This difference may be related to the early development of this testosterone ester as a commercial drug product. The main use of testosterone cypionate in clinical medicine has historically been the treatment of low androgen levels in men, although many other applications of the drug exist. For example, in the 1960s, prescribing recommendations for the drug called for supporting the maturation of bone structure, in the treatment of menorrhagia (heavy menstrual bleeding) in women and excessive lactation in women, to increase muscle mass and to combat osteoporosis in the elderly. It is also recommended to improve male fertility, induce testosterone/spermatogenesis suppression (testosterone cypionate 200 mg weekly for 6 to 10 weeks), there may be a period of rebound spermatogenesis (temporarily higher than normal gonadotropin) levels). By the 1970s, the FDA had gained stronger control over the prescription drug market and, for the first time, indicated that the widespread use of testosterone cypionate was now improving. For example, "testosterone rebound therapy" proved unreliable as a method of increasing male fertility, especially in the face of newer, more effective drugs, and was quickly eliminated from prescribing guidelines. The same goes for recommendations for treating problems such as excessive menstrual bleeding and breastfeeding. In general, the return of testosterone therapy has been focused on androgen deficiency in men and less on other applications, especially when it comes to populations more susceptible to androgen side effects, such as women and the elderly. Today, testosterone cypionate remains readily available on the U.S. prescription drug market and is FDA-approved for hormone replacement therapy in men with conditions associated with endogenous testosterone deficiency and as a secondary treatment for inoperable metastatic breast cancer in women. level treatment (although it is no longer widely used for this purpose).
Testosterone Cypionate Common Product Specifications:
Testosterone cypionate is widely used in the human and veterinary markets. Formulation and dosage can vary according to the country and manufacturer, common dosage specifications are: 50mg/ml, 100mg/ml, 125mg/ml or 200mg/ml, usually loaded in 10ml vials or 1ml ampoules.
Structural characteristics of testosterone cypionate:
Testosterone cypionate is a modified form of testosterone in which cypionate has been attached to the 17-beta hydroxyl group. The esterified form of testosterone is less polar than free testosterone and absorbs more slowly from the injection area. Once in the bloodstream, the ester is removed, leaving free (active) testosterone. The esterified form of testosterone is designed to prolong the window of therapeutic effect after administration, allowing for a less frequent injection regimen than injecting the free (non-esterified) steroid. About 8 days after injection, testosterone cypropionate has a half-life of about 8 days.
Testosterone Cypionate Uses:
Prescribing guidelines for testosterone cypionate call for a dose of 50-400 mg every two to four weeks in the treatment of low testosterone levels. Despite prolonged in vivo activity, weekly injections of testosterone cypionate are often required to achieve muscle growth or improved athletic performance. The usual dosage is 200-600mg per week in cycles of 6 to 12 weeks. This level is enough for most people to notice significant increases in muscle size and strength. While high doses are generally not recommended, some bodybuilders have been known to use very large doses of testosterone cypionate (1,000mg or more per week). This was more common before the 1990's when testosterone cypionate was usually very cheap and easy to find compared to today. At doses of 800-1000mg per week or more, water storage may account for more of the excess body weight gain than new muscle tissue. The practice of "high doses" is ineffective (not to mention potentially dangerous), especially when we consider the current high prices of steroids.
testosterone cypionate for women
Testosterone cypionate is rarely used by women in clinical medicine. When applied, it is often used as a secondary agent during inoperable breast cancer when other therapies have failed to produce the desired effect and suppression of ovarian function is required. Testosterone cypionate is not recommended for use in women due to its strong androgenic properties, tendency to produce virilizing side effects, and slow-acting profile (making blood levels difficult to control).
Any needs, please contact us
Email: amyraws195@gmail.com
Whatsapp: +86-17507125642
Telegram: +86-17507125642
Hot Tags: testosterone cypionaye 200 stada us domestic shipping 5-7days, China testosterone cypionaye 200 stada us domestic shipping 5-7days manufacturers, suppliers, factory, Testosterone Undecanoate CAS 5949 44 0, Clenbuterol STADA US Domestic, Deca 200 Oil Nandrolone Decanoate, Nandrolone Phenylpropionate CAS 62 90 8 200mg, CAS 58-20-8, Tren E 200 CAS 472 61 5
